The top 10 biopharma M&A deals of 2023
Source: Fierce Pharma While the biopharma industry’s dealmaking totals have yet to eclipse the heady highs of 2019, mergers and acquisitions were back on the menu in a big way in 2023. Last year, the value of the top 10 M&A deals in the biopharma industry came to $115.8 billion, outranking prior sums from 2022, […]